A global fund based in Israel with over $1.3B AUM, aMoon leverages the pioneering scientific research, raw talent, and do-the-impossible culture of the Startup Nation. As Israel’s largest HealthTech VC fund, we partner with outstanding entrepreneurs who harness groundbreaking science and technology to transform healthcare and help people live better, healthier lives. aMoon invests across all stages of a company’s lifecycle through three investment vehicles: aMoon Velocity, our early-stage fund, aMoon Growth, our mid-late-stage fund, and aMoon Edge, our public equities fund. We leverage our multidisciplinary team of over 50 scientists, physicians, and entrepreneurs, along with our robust network of investors and industry leaders, to build bridges between our portfolio companies and global HealthTech hubs, supporting entrepreneurs from the inception of an idea to company launch.